Remus Stoica

Dr. Remus Stoica

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
LGLaurentia Nicoleta Gales
Laurentia Nicoleta Gales
DMDiana Andreea Mitrea
Diana Andreea Mitrea
BCBogdan Mihai Chivu
Bogdan Mihai Chivu
ARAdrian Radu
Adrian Radu
SBSilvia Bocai
Silvia Bocai
LSLuiza Serbanescu
Luiza Serbanescu
Metastatic lesions of the spine occur in up to 40% of cancer patients and are a frequent source of pain and neurologic deficit due to cord compression. Palliative radiotherapy is the main first-intent local treatment in the form of single-fraction radiotherapy or fractionated courses. Reirradiation is a viable option for inoperable patients where spinal decompression is needed but with an increased risk of radiation-induced myelopathy (RM) and subsequent neurologic damage. This review summarizes reported data on local treatment options after initial irradiation in patients with relapsed spine metastasis and key dosimetric correlations between the risk of spinal cord injury and reirradiation technique, total dose, and time between treatments. The Linear Quadratic (LQ) model was used to convert all the published doses into biologically effective doses and normalize them to EQD2. For 3D radiotherapy, authors used cumulative doses from 55.2 Gy2/2 to 65.5 Gy2/2 EQD2 with no cases of RM mentioned. We found little evidence of RM after SBRT in the papers that met our criteria of inclusion, usually at the median reported dose to critical neural tissue around 93.5 Gy2/2. There is a lack of consistency in reporting the spinal cord dose, which leads to difficulty in pooling data.

3 December 2025 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
MDMianyong Ding
Mianyong Ding
MMMatteo Maspero
Matteo Maspero
Semi B HarrabiSemi B Harrabi
Semi B Harrabi
EJEmmanuel Jouglar
Emmanuel Jouglar
SVSabina Vennarini
Sabina Vennarini
GJGeert O. Janssens
Geert O. Janssens
We appreciate the commentary from Saad et al., which offers an opportunity to clarify key methodological and clinical aspects of our study assessing the impact of deep learning–based CT auto-contouring for organ-at-risk delineation in paediatric flank irradiation for renal tumours. First, the annotation protocol was provided in the original Supplementary Materials, and additional delineation instructions followed established SIOP-RTSG standards. Second, as already mentioned in the manuscript discussion, we acknowledge the inherent bias associated with STAPLE consensus contours, and we addressed this by including an additional single-expert reference in our evaluation. Third, although dose analysis can provide valuable clinical insights, it is not essential at this stage, as geometric evaluation remains the main benchmark for validating auto-contouring performance. Fourth, while uncertainty quantification is a promising research direction, our study was designed to reflect current clinical practice, where uncertainty-aware segmentation has not yet been integrated into routine auto-segmentation systems. Finally, we recognize that our controlled workshop environment does not fully reflect real-world clinical workflows, a limitation already discussed in our original manuscript. We hope these clarifications foster a balanced understanding of our work and support ongoing efforts toward the safe and effective clinical adoption of AI-assisted contouring in paediatric radiotherapy.